Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Alamos Gold -- Ignore unavailable to you. Want to Upgrade?

To: Al Collard who wrote (709)	12/9/2001 1:41:17 PM
From: pull_da_trigger	Read Replies (1) \| Respond to of 4470

I'm thinking that this could be my week with ONC. :) All last week there was a very large overhang of shares in between $7.45 and $7.50 (usually around 7-8,000 shares). It forced the stock to trade in a tight $0.30 range all week ($7.20 to $7.42 Mon-Thur) and then on Friday it broke through the overhang to close at $7.50 due to late day buying from Research Capital: 15:55:40 T 7.50 0.18 300 79 CIBC 2 DS 15:53:30 T 7.50 0.18 100 7 Green Line 2 DS 15:52:20 T 7.50 0.18 7200 83 Research Capital 2 DS 15:52:20 T 7.49 0.17 1000 83 Research Capital 7 Green Line 15:52:20 T 7.49 0.17 1800 83 Research Capital 44 Jones Gable The company has stated that it intends to provide an interim report on both safety and efficacy of their phase I trial by the end of this quarter. I can't see them wanting to release it in between Christmas and New Year's, and the week before Christmas wouldn't be ideal either with many people doing last minute shopping and travelling for the holidays. I'm betting that we see the news this week, since as an interim report, the timing is in their control. Just wanted to add some fundamental analysis to back up a pretty decent looking chart (IMO). Good luck everyone, P.D.T.